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It is well established that exposure to sunlight or ultraviolet radiation (UVR) is the major environmental risk factor
for the development of skin neoplasms. To date, however, there have been few appropriate mouse models available
for studying the role of UVR in melanoma carcinogenesis, mainly because of the murine lack of the epidermal
melanocyte, which is a major source of origin of human melanoma. In this study, we established xeroderma
pigmentosum group A gene-deﬁcient, stem cell factor-transgenic mice, which are defective in the repair of dam-
aged DNA and do have epidermal melanocytes. The mice were exposed to UVR three times a week for 10 wk. More
than 30% of the irradiated mice developed tumors of melanocyte origin that metastasized to the lymph nodes.
Histologically, proliferated cells exhibited lentigo maligna melanoma or nodular melanoma. Immunohistochemistry
conﬁrmed that the tumor cells were characteristic of melanoma. Non-irradiated mice did not develop skin tumors
spontaneously. The newly generated model mouse might be useful for studying the photobiological aspects of
human melanoma, because the mice developed melanoma from epidermal melanocytes only after UVR exposures.
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Melanoma, which originates from skin melanocytes, is one
of the most morbid and lethal diseases among the skin
disorders. The incidence rates of melanoma have steadily
increased for the past several decades all over the world
(Serraino et al, 1998). The rising incidence may be due in
part to increased recreational exposure to sunlight (Langley
et al, 1997). Elwood et al (1997) reviewed that a number of
retrospective epidemiological studies strongly suggest that
sunlight plays a critical role in the induction of cutaneous
melanoma. Investigations to clarify the functional role of ul-
traviolet radiation (UVR) in melanoma carcinogenesis, how-
ever, have been limited because of the lack of experimental
animals in which to induce experimental melanomas with
UVR. In contrast, the UVR mechanisms of action in the de-
velopment of non-melanoma skin cancers have been ex-
tensively studied in mammals (Blum, 1959; Fisher et al,
1987). It is now well established that DNA is a major chro-
mophore for UVR-induced cancers. Xeroderma pigmento-
sum (XP) is characterized by a high frequency of skin
cancers, including melanoma, on sun-exposed areas of the
body as a result of a defect in the early steps of nucleotide-
excision repair (Kraemer et al, 1994). We have previously
reported that group-A XP gene-deficient, XPA (/), mice
are highly susceptible to UVR-induced skin carcinogenesis
(Nakane et al, 1995). These mice easily and rapidly develop
squamous cell carcinoma (SCC) of keratinocyte origin, but
do not develop melanoma, presumably because of a lack in
epidermal melanocytes. The growth and differentiation of
melanocytes require stem cell factor (SCF), the ligand for
the c-Kit receptor tyrosine kinase. The lack of SCF expres-
sion in keratinocytes is thought to result in the amelanocytic
skin of the mouse except for the hair follicle. In contrast, the
continuous expression of SCF in human keratinocytes
maintains melanocytes in the skin (Yoshida et al, 1996;
Kunisada et al, 1998). Targeting the expression of SCF-
transgenic (SCF-Tg) to epidermal keratinocytes in mice with
transgenes under the control of the human keratin 14 pro-
moter resulted in epidermal melanocytosis, which produces
and transfers melanins to keratinocytes (Kunisada et al,
1998). We crossed XPA (/) mice and SCF-Tg mice, and
generated XPA (/), SCF-Tg mice (Yamazaki et al, 2004).
These mice possess a hairless and deeply black skin. The
epidermal melanin in the mice revealed a high inhibitory
activity against the enhanced photosensitivity of XPA (/)
mice. Although the epidermal melanocytes of XPA (/),
SCF-Tg mice can sufficiently protect keratinocytes against
UVR; melanocytes in these mice may be more sensitive
Abbreviations: HE, hematoxylin and eosin; LMM, lentigo maligna
melanoma; NM, nodular melanoma; SCC, squamous cell carcino-
ma; SCF, stem cell factor; UVR, ultraviolet radiation; XP, xeroderma
pigmentosum
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than those in XPA (þ /þ ) mice because of a defect in the
nucleotide excision repair of UVR-induced DNA damage. In
this study, an effort was made to induce cutaneous me-
lanoma by repeated exposures of a higher dose of UVR
onto XPA (/), SCF-Tg mice.1
Results and Discussion
Non-treated XPA (/), SCF-Tg mice, and XPA-normal,
SCF-Tg mice had black skin and hairs (Fig 1A, B). The ep-
idermal cells consisted of keratinocytes and clear cells with
abundant melanin in hematoxylin and eosin (HE)-stained
sections (Yamazaki et al, 2004). The latter were positive to
anti-S100 antibody immunohistochemically, thus consistent
with melanocytes or Langerhans cells (Fig 1C). No cells in
the epidermis or dermis are positive to anti-melanoma an-
tibodies (anti-HMB45 antibody and anti-MART-1 or Melan A
antibody) on immunohistochemical study (Fig 1D).
The mice at 8–10 wk of age were irradiated with UVB at a
dose of 5 J per cm2 on the back three times a week for 10
wk (total dose: 150 J per cm2). At the termination of the
exposure protocol, scaling, crusting, and/or ulceration was
observed on the irradiated back areas. At 4 mo after the
termination of UVR exposure, an unevenly pigmented ma-
cule with an irregular border appeared on the depigmented
skin that had re-epithelized after ulceration (Fig 2A). Histo-
logically, a proliferation of large, pleomorphic melanocytes
was found at the epidermal–dermal junction, revealing the
findings of lentigo maligna melanoma (LMM) in the HE-
stained sections (Fig 2B). When these skin lesions were left
untreated, the black macules became elevated tumors with
ulceration and an irregular border (Fig 2C, white arrow). On
histology, tumor cells with abundant melanin were found to
have invaded vertically into the deep dermis (Fig 2D). At
6 mo, some of the other mice developed black nodules on
the back (Fig 2E, white arrow) and ulcerated tumors ap-
peared (Fig 2E, dotted white arrow). Histology of the black
nodules revealed the findings of nodular melanoma (NM),
with a proliferation of atypical melanocytes in the dermis in
connection with the epidermis (Fig 2F). Tumor cells were so
heavily pigmented that bleaching was required for
immunohistochemical observations (Fig 3D–F). Monoclon-
al antibodies revealed that they were positive for the S-100
protein, melanoma antibodies (a mixture of anti-HMB-45
antibody and MART-1 or Melan A antibody), and the Ki-67
antibody (Fig 3D–F). The Ki-67 positive ratio was 18.1% in
NM and 9.8% in LMM. Basal melanocytes of the non-ex-
posed XPA (/), SCF-Tg mouse were positive only for the
S-100 protein. The number of mice bearing LMM or NM
gradually increased over time. At the end of the observation
period of 58 wk after the start of UVR exposure, 12 and
eight of 61 irradiated mice had developed LMM and NM,
respectively. Twenty-three mice died before developing
tumors because of persistent severe sunburn. Consequent-
ly, 33% (20 of 61) of irradiated mice, and 53% (20 of 38) of
the survivors developed melanoma. Interestingly, individual
mice developed either LMM or NM, but not both. All of the
LMM were induced on the re-epithelized skin after severe
burning, whereas NM appeared on the skin without pre-
ceding ulceration. Six of eight mice with NM developed
multiple tumors, and the remaining two bore a solitary
tumor. Four mice developed skin tumors that were histo-
logically confirmed to be SCC revealing proliferation of
atypical keratinocytes with frequent mitotic figures, during a
period of 4–8 mo after the discontinuation of UVR exposure
(Fig 2E, dotted white arrow, Fig 2G). Three of these also
developed NM associated with SCC, but the remaining
mouse had NM alone. No tumor was induced in the non-
irradiated XPA (/), SCF-Tg mice, or the irradiated SCF-Tg
(XPA normal (þ /þ )) mice. Animals with skin melanomas
were euthanized at various time points. The axillar and in-
guinal lymph nodes were collected for histological exami-
nation. Melanoma metastasis was found in four of 12 mice
with LMM and in seven of eight with NM (Fig 4A and B).
There were possible melanocytes bearing melanin granules
in lymph nodes in the HE-stained section from non-irradi-
ated mice. But they were negative immunohistochemically
for anti-melanoma antibodies. Two pathologists experi-
enced with melanoma evaluated the HE and immunohisto-
chemically stained sections.
Walker reviewed that the development of animal models
of melanoma has been undertaken by a number of inves-
tigators (Walker et al, 2002). There have been few previous
reports of melanoma induction in experimental animals by
UVR alone. Melanoma was induced in platyfish–swordtail
hybrid fish by UVA and a visible range of light, which are not
absorbed directly in DNA (Setlow et al, 1993). The question
remains, however, whether these experimental data are di-
rectly applicable to human melanoma since there are great
differences in the structure of the skin and in the environ-
ment between fish and humans. In terms of a mammalian
model, the South American opossum, Monodelphis domes-
tica, was exposed to UVR three times a week for 70 wk, and
Figure1
Clinical and histological features of non-treated xeroderma
pigmentosum (XP)A (/), stem cell factor-transgenic (SCF)-Tg
mouse and XPA normal (þ /þ ), SCF-Tg mouse. XPA (/); SCF-Tg
mouse has uniformly black skin (A) and XPA (þ /þ ), SCF-Tg mouse
has black hair and skin (B). Keratinocytes contain abundant melanin in
hematoxylin and eosin staining (Yamazaki et al, 2004), and clear cells
are positive for anti-S100 antibody in the immunohistochemical staining
(C). In non-treated skin, neither epidermal nor dermal cells are positive
for anti-melanoma antibody (D). C and D are of the same magnification,
and the bar in D indicates 200 mm.
1Yamazaki F, Okamoto H, Matsumura Y, Tanaka K, Kunisada T,
Horio T: Development of a new mouse model of UVB-induced
melanoma. Pigment Cell Res 17: 684–685, 2004 (abstr).
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developed melanotic tumors in the dermis at 100 wk after
the first exposure (Ley et al, 1989). Since this animal
possesses a photoreactivation repair pathway for DNA
damage, the induction of melanocyte hyperplasia was sup-
pressed by the exposure of photoreactivating light (4320
nm) after UVR, indicating that DNA damage by UVR is
linked to the melanoma development. The mouse has been
used as a useful and convenient experimental animal to
study the effect of UVR on non-melanoma skin cancers. To
investigate the role of UVR on melanomagenicity, it is help-
ful to generate an animal model that develops melanoma
after UVR exposure. The wild-type mouse, however, has not
been a suitable model for melanoma investigation, since the
mouse does not have epidermal melanocytes, although the
colored mouse has melanocytes in the dermis and hair fol-
licle. In inbred mice, melanoma has been induced by UVR in
combination with chemical carcinogens (Romerdahl et al,
1989; Hussain et al, 1991). Recently, genetically engineered
mouse models have been established for the study of me-
lanomagenesis. In some of them, melanomas developed
spontaneously, but were enhanced by UVR (hepatocyte
growth factor/scatter factor (HGF/SF mouse)) (Noonan et al,
2000), and in other mice melanomas occurred only when
chronically exposed to UVR, but from dermal melanocytes
(Kelsall et al, 1998; Powell et al, 1999). Until recently, the
responsible spectrum of UVR for melanomagenesis has not
been experimentally identified. De Fabo revealed that UVB
but not UVA radiation-initiated melanomas in HGF/SF
mouse (De Fabo et al, 2004). In this experiment, the mice
were exposed mainly to UVB, since XPA (/) mice have a
defect in repair of DNA damage of cyclobutane pyrimidine
dimmer-type that is induced by UVB. The melanin pigment
Figure3
Immunohistochemical staining of skin tumor specimens after a
bleaching treatment of melanin. Lentigo maligna melanoma (LMM)
(A–C) and nodular melanoma (NM) (D–F) were positive for the anti-S100
antibody, anti-melanoma antibodies, and the anti-Ki67 antibody show-
ing brownish staining. Squamous cell carcinoma (SCC) (G–I) was neg-
ative for the anti-S100 and anti-melanoma antibodies, and positive for
the anti-Ki67 antibody. All photographs are of the same magnification,
and the bar in Fig 1 indicates 200 mm.
Figure2
Lentigo maligna melanoma (LMM), nodular melanoma (NM), and
squamous cell carcinoma (SCC) developed on the irradiated skin
of the xeroderma pigmentosum (XP)A (/), stem cell factor-
transgenic (SCF)-Tg mouse. Black macules with irregular border (ar-
row) appeared on the re-epithelized, depigmented back skin of the
ultraviolet (UV)-irradiated mouse at 4 mo after termination of UVR ex-
posure (a total amount of 150 J per cm2 UVB) (A), and histology re-
vealed the findings of LMM with large and atypical cells with abundant
melanin mainly in the epidermal–dermal junction on hematoxylin and
eosin (HE) staining (B). Elevated tumors with ulceration and an irregular
border developed on the black macule (C, white arrow). In histology,
tumor cells with abundant melanin invaded vertically into the deep de-
rmis (D). In other mice, nodules developed on the irradiated skin with-
out preceding ulcer and depigmentation (white arrow) and an ulcerated
tumor appeared after 6 mo of UVR (E, dotted white arrow). Histological
findings of the solid black tumors were compatible with those of NM,
revealing a proliferation of melanocytes with massive melanin down
into the dermis in connection with the epidermis on HE staining (F). The
ulcerated tumor was histologically diagnosed as SCC composed of
atypical keratinocytes without melanin (G). (H) Melanoma-occurrence
percentage of the mice. The x-axis indicates the time course after the
termination of UVB exposure. The y-axis indicates the percentage of
melanoma-developed mice. About 55% of UV-treated XPA (/), SCF-
Tg mice developed melanoma at 70 wk after UVB radiation. UV-treated
XPA-normal, SCF-Tg mice and non-treated XPA (/), SCF-Tg mice
did not develop melanoma. The bar in B indicates 200 mm. D and F are
of the same magnification, and bars indicate 1.5 mm. The bar in G
indicates 100 mm.
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is classified into two types: eumelanin and pheomelanin.
Some in vitro investigations indicate that pheomelanin has
cytotoxicity by UVA radiation and relate to UVA carcino-
genesis of melanoma (Jimbow et al, 1991). We have not
analyzed the type of melanin in this experiment.
We previously reported that a defect in the nucleotide
excision repair of damaged DNA in XPA (/) mice causes
an extreme susceptibility to UVR-induced skin cancers
(Nakane et al, 1995), enhanced immunosuppression (Mi-
yauchi-Hashimoto et al, 1996; Kuwamoto et al, 2000; Mi-
yauchi-Hashimoto et al, 2001), and inactivation of natural
killer cells (Miyauchi-Hashimoto et al, 1999). The cancers
induced were SCC that developed from epidermal keratin-
ocytes. XPA (/), SCF-Tg mice with epidermal me-
lanocytes were highly resistant to UVR, and developed
neither SCC nor MM even after repeated exposures to UVB
for 30 wk at a total dose of 72 J per cm2 (Yamazaki et al,
2004). In this study, the mice were repeatedly exposed to
5 J per cm2 of UVB at a total dose of 150 J per cm2 over
10 wk and resulted in the frequent development of
melanoma. The dose of UV was very high compared with
models that have been established by other investigators.
This discrepancy seems to be mainly because of extremely
dark skin with heavily pigmented epidermal keratinocytes
and melanocytes in the present mice. The severe inflam-
mation, which was induced by repeated exposures to high
doses of UVR, may be partly involved in melanoma pro-
gression, as it is widely accepted that inflammation is a
critical factor in tumor progression (Coussens et al, 2002).
We rarely observed SCC in DNA repair-deficient mice even
after exposures to a huge amount of UVB, indicating that
melanocytes effectively protect keratinocytes against ma-
lignant transformation. The mouse generated in this study is
a new animal model of melanoma in that melanoma oc-
curred from epidermal melanocytes only after and as a re-
sult of experimental UVR exposure. Although melanoma
was experimentally induced in the mice by exposure to an
unusually high dose of UVB, we are currently generating
XPA (/), SCF-Tg mice with a lighter skin color for clin-
ically relevant investigations. This is the initial step toward
establishing a model of melanoma that will allow close in-
vestigation of the development of the pathology in connec-
tion to light exposure. There have been several reports that
mutation patterns were different (deletion, insertion, and
point mutation) among clinical stages of melanomas in the
tumor suppressor genes (Kannan et al, 2003). We are going
to analyze the mutation of tumor suppressor genes in me-
lanomas experimentally developed in XPA (/), SCF-Tg
mice.
In conclusion, we have generated a mammalian model
that can develop melanocyte tumor after UVR exposure
with proliferating and metastasizable ability.
Materials and Methods
Mice Hairy XPA (/) mice with a CBA, C57BL/6, and CD-1 chi-
meric genetic background (Nakane et al, 1995) were backcrossed
with hairless albino mice of the inbred strains Hos/HR-1, and the
resultant hairless XPA (/). A hairy SCF-Tg mouse has a C57BL/6
and SLJ background (Kunisada et al, 1998). XPA (/) mice and
SCF-Tg mice were crossed and the resultant hairy XPA (þ /),
SCF-Tg mice were generated. Thereafter, offspring of XPA (þ /),
SCF-Tg mice, and hairless XPA (/) mice were backcrossed, re-
sulting in hairless XPA (/), SCF-Tg mice (Yamazaki et al, 2004).
We used 61 XPA (/), SCF-Tg mice in this experiment. As control
mouse, we used 20 XPA normal, SCF-Tg mice (Kunisada et al,
1998) and unexposed 20 XPA (/), SCF-Tg mice. All mice were
8–10 wk of age at the beginning of each experiment. The maximum
observation interval was 2 y. Mouse experiments were approved
by the Kansai Medical University Subcommittee on Research
Animal Care.
Induction of skin tumors by UV irradiation The UVB source was
a bank of fluorescent sunlamps (FL.20SE.30; Toshiba Medical
Supply, Tokyo, Japan) that emit approximately 55% of their radi-
ation within the UVB range peaking at 305 nm, 25% and less than
1%, within UVA and UVC, respectively. The irradiance of UVB was
measured by a radiometer (UVR-305/365D (II); Toshiba Medical
Supply). XPA (/) SCF-Tg mice, XPA normal, and SCF-Tg mice
were irradiated with 5 J per cm2 of UVB on the back three times a
week.
Histological examination of tumors Skin samples and tumor
samples were prepared from mice. A 5 mm section was stained
with HE. For the immunohistochemical analysis, melanin in the
Figure 4
Histology of a metastatic lesion in the lymph nodes. (A) Atypical
large cells with abundant melanin were observed in a hematoxylin and
eosin-stained section of an axillar lymph node from the mice that had
developed nodular melanoma. (B) The atypical cells were positive for
the melanoma antibodies on immunohistochemical staining after a
bleaching treatment of melanin. All photographs are of the same mag-
nification, and the bar in Fig 1 indicates 200 mm.
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deparaffinized sections was bleached by 0.25% potassium per-
manganate for 1 h, and 2% oxalic acid for 1 min. The specimens
were reincubated for 10 min in 10% normal goat serum, and treat-
ed with target retrieval solution (DAKO, Carpinteria, California) and
incubated for 12 h at 41C with monoclonal antibodies including
anti-melanoma antibody (anti-HMB45 antibody and anti-MART-1
or Melan A antibody, ab732, abcam, Cambridge, UK), anti-S100
antibody (ab4066, abcam, Cambridge, UK), and anti-Ki-67 anti-
body (NCL-Ki67-MM1, Novocastra Laboratories, Newcastle, UK).
After three washes with phosphate-buffered saline (PBS) plus
0.5% Tween, the sections were incubated for 15 min with a biotin-
conjugated secondary antibody (Vector Laboratories, Burlingame,
California). After three washes with PBS plus 0.5% Tween, the
slides were treated with diaminobenzidine (Vectastain Elite ABC kit,
Vector Laboratories) as recommended by the manufacturer. Coun-
terstaining was performed with hematoxylin. As a negative control,
tissue sections were stained with the secondary antibody only.
Positive staining is brownish for all antibodies in immunohisto-
chemistry. In each case, a minimum of 1000 tumor cells were ob-
served, and the results were expressed as the percentage of Ki-67
positive cells.
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